Clinical Trial Update: Vitamin D for Sickle-cell Respiratory Complications [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating Vitamin D supplementation for respiratory complications in sickle cell disease has completed and results were posted in 2024.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma
• Chest Syndrome
• Respiratory Infections
• Sickle Cell Disease
• Vitamin Deficiency

Drugs mentioned

• Vitamin D3 (Cholecalciferol) (Cholecalciferol)

Snippet

Sponsor: Gary M Brittenham, MD | Conditions: Sickle Cell Disease, Vitamin D Deficiency | Phase 2 | Status: COMPLETED | Results posted: 2024-08-09